Glioblastoma in adults
Glioblastoma is the most common form of primary brain cancer in adults, and the disease has a serious prognosis. Although great progress has been made in molecular characteristics, no major breakthroughs in treatment have been achieved for many years. In this article we present a clinical review of...
Gespeichert in:
| Veröffentlicht in: | Tidsskrift for den Norske Lægeforening 2023-01, Vol.143 (2) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | nor |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | |
| container_title | Tidsskrift for den Norske Lægeforening |
| container_volume | 143 |
| creator | Schipmann-Miletic, Stephanie Sivakanesan, Sarankan Rath, Daniel Stavne Brandal, Petter Vik-Mo, Einar Bjørås, Magnar Solheim, Ole Ingebrigtsen, Tor Sund, Fredrik Bjerkvig, Rolf Miletic, Hrvoje Johannessen, Tor-Christian Aase Sundstrøm, Terje |
| description | Glioblastoma is the most common form of primary brain cancer in adults, and the disease has a serious prognosis. Although great progress has been made in molecular characteristics, no major breakthroughs in treatment have been achieved for many years. In this article we present a clinical review of current diagnostics and treatment, as well as the challenges and opportunities inherent in developing improved and more personalised treatment. |
| doi_str_mv | 10.4045/tidsskr.22.0314 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_36718891</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>36718891</sourcerecordid><originalsourceid>FETCH-pubmed_primary_367188913</originalsourceid><addsrcrecordid>eNpjYBA3NNAzMTAx1S_JTCkuzi7SMzLSMzA2NGFi4DSwMDDXNTewNONg4CouzjIwMLIwM7RkZ-AwNjM3tLCwNORkEHPPycxPykksLsnPTVTIzFNITCnNKSnmYWBNS8wpTuWF0twMcm6uIc4eugWlSbmpKfEFRZm5iUWV8TCDjAkqAADGIy0m</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Glioblastoma in adults</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Norart Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Schipmann-Miletic, Stephanie ; Sivakanesan, Sarankan ; Rath, Daniel Stavne ; Brandal, Petter ; Vik-Mo, Einar ; Bjørås, Magnar ; Solheim, Ole ; Ingebrigtsen, Tor ; Sund, Fredrik ; Bjerkvig, Rolf ; Miletic, Hrvoje ; Johannessen, Tor-Christian Aase ; Sundstrøm, Terje</creator><creatorcontrib>Schipmann-Miletic, Stephanie ; Sivakanesan, Sarankan ; Rath, Daniel Stavne ; Brandal, Petter ; Vik-Mo, Einar ; Bjørås, Magnar ; Solheim, Ole ; Ingebrigtsen, Tor ; Sund, Fredrik ; Bjerkvig, Rolf ; Miletic, Hrvoje ; Johannessen, Tor-Christian Aase ; Sundstrøm, Terje</creatorcontrib><description>Glioblastoma is the most common form of primary brain cancer in adults, and the disease has a serious prognosis. Although great progress has been made in molecular characteristics, no major breakthroughs in treatment have been achieved for many years. In this article we present a clinical review of current diagnostics and treatment, as well as the challenges and opportunities inherent in developing improved and more personalised treatment.</description><identifier>EISSN: 0807-7096</identifier><identifier>DOI: 10.4045/tidsskr.22.0314</identifier><identifier>PMID: 36718891</identifier><language>nor</language><publisher>Norway</publisher><subject>Adult ; Brain Neoplasms - diagnostic imaging ; Brain Neoplasms - therapy ; Glioblastoma - diagnosis ; Glioblastoma - therapy ; Humans ; Prognosis</subject><ispartof>Tidsskrift for den Norske Lægeforening, 2023-01, Vol.143 (2)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-6503-7141 ; 0000-0001-5966-9786</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,861,27906,27907</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36718891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schipmann-Miletic, Stephanie</creatorcontrib><creatorcontrib>Sivakanesan, Sarankan</creatorcontrib><creatorcontrib>Rath, Daniel Stavne</creatorcontrib><creatorcontrib>Brandal, Petter</creatorcontrib><creatorcontrib>Vik-Mo, Einar</creatorcontrib><creatorcontrib>Bjørås, Magnar</creatorcontrib><creatorcontrib>Solheim, Ole</creatorcontrib><creatorcontrib>Ingebrigtsen, Tor</creatorcontrib><creatorcontrib>Sund, Fredrik</creatorcontrib><creatorcontrib>Bjerkvig, Rolf</creatorcontrib><creatorcontrib>Miletic, Hrvoje</creatorcontrib><creatorcontrib>Johannessen, Tor-Christian Aase</creatorcontrib><creatorcontrib>Sundstrøm, Terje</creatorcontrib><title>Glioblastoma in adults</title><title>Tidsskrift for den Norske Lægeforening</title><addtitle>Tidsskr Nor Laegeforen</addtitle><description>Glioblastoma is the most common form of primary brain cancer in adults, and the disease has a serious prognosis. Although great progress has been made in molecular characteristics, no major breakthroughs in treatment have been achieved for many years. In this article we present a clinical review of current diagnostics and treatment, as well as the challenges and opportunities inherent in developing improved and more personalised treatment.</description><subject>Adult</subject><subject>Brain Neoplasms - diagnostic imaging</subject><subject>Brain Neoplasms - therapy</subject><subject>Glioblastoma - diagnosis</subject><subject>Glioblastoma - therapy</subject><subject>Humans</subject><subject>Prognosis</subject><issn>0807-7096</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpjYBA3NNAzMTAx1S_JTCkuzi7SMzLSMzA2NGFi4DSwMDDXNTewNONg4CouzjIwMLIwM7RkZ-AwNjM3tLCwNORkEHPPycxPykksLsnPTVTIzFNITCnNKSnmYWBNS8wpTuWF0twMcm6uIc4eugWlSbmpKfEFRZm5iUWV8TCDjAkqAADGIy0m</recordid><startdate>20230131</startdate><enddate>20230131</enddate><creator>Schipmann-Miletic, Stephanie</creator><creator>Sivakanesan, Sarankan</creator><creator>Rath, Daniel Stavne</creator><creator>Brandal, Petter</creator><creator>Vik-Mo, Einar</creator><creator>Bjørås, Magnar</creator><creator>Solheim, Ole</creator><creator>Ingebrigtsen, Tor</creator><creator>Sund, Fredrik</creator><creator>Bjerkvig, Rolf</creator><creator>Miletic, Hrvoje</creator><creator>Johannessen, Tor-Christian Aase</creator><creator>Sundstrøm, Terje</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><orcidid>https://orcid.org/0000-0002-6503-7141</orcidid><orcidid>https://orcid.org/0000-0001-5966-9786</orcidid></search><sort><creationdate>20230131</creationdate><title>Glioblastoma in adults</title><author>Schipmann-Miletic, Stephanie ; Sivakanesan, Sarankan ; Rath, Daniel Stavne ; Brandal, Petter ; Vik-Mo, Einar ; Bjørås, Magnar ; Solheim, Ole ; Ingebrigtsen, Tor ; Sund, Fredrik ; Bjerkvig, Rolf ; Miletic, Hrvoje ; Johannessen, Tor-Christian Aase ; Sundstrøm, Terje</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_367188913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>nor</language><creationdate>2023</creationdate><topic>Adult</topic><topic>Brain Neoplasms - diagnostic imaging</topic><topic>Brain Neoplasms - therapy</topic><topic>Glioblastoma - diagnosis</topic><topic>Glioblastoma - therapy</topic><topic>Humans</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schipmann-Miletic, Stephanie</creatorcontrib><creatorcontrib>Sivakanesan, Sarankan</creatorcontrib><creatorcontrib>Rath, Daniel Stavne</creatorcontrib><creatorcontrib>Brandal, Petter</creatorcontrib><creatorcontrib>Vik-Mo, Einar</creatorcontrib><creatorcontrib>Bjørås, Magnar</creatorcontrib><creatorcontrib>Solheim, Ole</creatorcontrib><creatorcontrib>Ingebrigtsen, Tor</creatorcontrib><creatorcontrib>Sund, Fredrik</creatorcontrib><creatorcontrib>Bjerkvig, Rolf</creatorcontrib><creatorcontrib>Miletic, Hrvoje</creatorcontrib><creatorcontrib>Johannessen, Tor-Christian Aase</creatorcontrib><creatorcontrib>Sundstrøm, Terje</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Tidsskrift for den Norske Lægeforening</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schipmann-Miletic, Stephanie</au><au>Sivakanesan, Sarankan</au><au>Rath, Daniel Stavne</au><au>Brandal, Petter</au><au>Vik-Mo, Einar</au><au>Bjørås, Magnar</au><au>Solheim, Ole</au><au>Ingebrigtsen, Tor</au><au>Sund, Fredrik</au><au>Bjerkvig, Rolf</au><au>Miletic, Hrvoje</au><au>Johannessen, Tor-Christian Aase</au><au>Sundstrøm, Terje</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glioblastoma in adults</atitle><jtitle>Tidsskrift for den Norske Lægeforening</jtitle><addtitle>Tidsskr Nor Laegeforen</addtitle><date>2023-01-31</date><risdate>2023</risdate><volume>143</volume><issue>2</issue><eissn>0807-7096</eissn><abstract>Glioblastoma is the most common form of primary brain cancer in adults, and the disease has a serious prognosis. Although great progress has been made in molecular characteristics, no major breakthroughs in treatment have been achieved for many years. In this article we present a clinical review of current diagnostics and treatment, as well as the challenges and opportunities inherent in developing improved and more personalised treatment.</abstract><cop>Norway</cop><pmid>36718891</pmid><doi>10.4045/tidsskr.22.0314</doi><orcidid>https://orcid.org/0000-0002-6503-7141</orcidid><orcidid>https://orcid.org/0000-0001-5966-9786</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 0807-7096 |
| ispartof | Tidsskrift for den Norske Lægeforening, 2023-01, Vol.143 (2) |
| issn | 0807-7096 |
| language | nor |
| recordid | cdi_pubmed_primary_36718891 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Norart Open Access; EZB-FREE-00999 freely available EZB journals |
| subjects | Adult Brain Neoplasms - diagnostic imaging Brain Neoplasms - therapy Glioblastoma - diagnosis Glioblastoma - therapy Humans Prognosis |
| title | Glioblastoma in adults |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T10%3A59%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glioblastoma%20in%20adults&rft.jtitle=Tidsskrift%20for%20den%20Norske%20L%C3%A6geforening&rft.au=Schipmann-Miletic,%20Stephanie&rft.date=2023-01-31&rft.volume=143&rft.issue=2&rft.eissn=0807-7096&rft_id=info:doi/10.4045/tidsskr.22.0314&rft_dat=%3Cpubmed%3E36718891%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/36718891&rfr_iscdi=true |